256 unknown. 256 Phase 3, 83 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 256 | Unknown 256 |
| Phase 2 | 83 | Unknown 83 |
Follow Mental Disorders: new trials by email Literature Review of Mental Disorders trials Research Report on Mental Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women 0.20% sodium hyaluronate gel - Vaginismus, Vaginal Atrophy | Phase 3 | Unknown | Biolab Sanus Farmaceutica | 45 | 2025-03-01 | 2024-08-21 |
| Cannabidiol's Role in Dementia Management Cannabidiol Oil - Dementia, Vascular, Dementia, Mixed | Phase 2 / Phase 3 | Unknown | Hospital Pengajar Universiti Putra Malaysia | 486 | 2024-09-01 | 2024-07-23 |
| A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1 NLS-2, Placebo - Narcolepsy Type 1, Narcolepsy With Cataplexy | Phase 3 | Unknown | NLS Pharmaceutics | 48 | 2024-07-15 | 2024-05-21 |
| Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation Toronto association, Tadalafil, Tadalafil placebo - Erectile Dysfunction, Premature Ejaculation | Phase 3 | Unknown | EMS | 232 | 2024-07-01 | 2023-04-12 |
| Efficacy and Safety of NestaCell® in Huntington's Disease NestaCell® - Huntington Disease | Phase 3 | Unknown | Azidus Brasil | 120 | 2024-06-08 | 2023-10-24 |
| Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia Sublingual Tablet - Chronic Insomnia | Phase 3 | Unknown | EMS | 358 | 2024-06-01 | 2023-09-07 |
| Genetic Factors of Erectile Dysfunction Degree and Response to Tadalafil Treatment in Patients With Diabetes Tadalafil 5mg - Erectile Dysfunction With Diabetes Mellitus | Phase 3 | Unknown | University Medical Centre Ljubljana | 90 | 2024-05-17 | 2024-07-25 |
| Dexmedetomidine Premedication for Post-anaesthesia Sleep Disturbance Normal Saline, Dexmedetomidine - Postoperative Sleep Disturbance | Phase 3 | Unknown | The First Affiliated Hospital of Xiamen University | 110 | 2024-05-01 | 2024-04-16 |
| Effect of Intravenous Nalbuphine and Magnesium Sulfate on Emergence Agitation in Pediatric Nalbuphine Versus Magnesium Sulfate - Emergence Delirium | Phase 3 | Unknown | Assiut University | 105 | 2024-04-02 | 2024-03-12 |
| An Open-Label, Single Arm Study of the Efficacy of Accelerated Intermittent Theta Burst Stimulation in Schizophrenia Patients With Persistent Negative Symptoms Accelerated iTBS - Schizophrenia; Negative Type | Phase 3 | Unknown | Institute of Mental Health, Singapore | 40 | 2024-04-01 | 2024-04-08 |
| Efficacy of MAD as add-on Therapy in Comparison With Standard of Care in Children With ASD Modified Atkin's Diet with standard of care, Standard of Care - Modified Atkins Diet, Autism Spectrum Disorder | Phase 2 / Phase 3 | Unknown | All India Institute of Medical Sciences | 80 | 2024-03-20 | 2024-03-18 |
| Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD Behavior therapy, Psychoeducation - Autism Spectrum Disorder | Phase 2 / Phase 3 | Unknown | Stanford University | 90 | 2024-01-05 | 2024-08-27 |
| The Effect of Clonidine-enhanced Sedation on Delirium in Ventilated Critically Ill Patients Clonidine, SodiumChloride - Delirium | Phase 3 | Unknown | Deventer Ziekenhuis | 115 | 2024-01-01 | 2023-02-15 |
| Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder Glecaprevir/pibrentasvir, Placebo - PTSD | Phase 2 / Phase 3 | Unknown | White River Junction Veterans Affairs Medical Center | 92 | 2023-12-18 | 2025-04-24 |
| Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
Showing 20 of 256. Sign in to see all of them.
Schizophrenia (24) · Alzheimer Disease (19) · Depression (17) · Erectile Dysfunction (17) · Cognitive Dysfunction (16) · Anxiety Disorders (15) · Depressive Disorder, Major (14) · Marijuana Abuse (14) · Stress Disorders, Post-Traumatic (12) · Agnosia (10) · Bipolar Disorder (10) · Pain (10) · Chronic Pain (9) · Sleep Initiation and Maintenance Disorders (9) · Opioid-Related Disorders (8)
Nervous System Diseases (88) · Pathological Conditions, Signs and Symptoms (72) · Signs and Symptoms (59) · Neurocognitive Disorders (54) · Neurologic Manifestations (49) · Chemically-Induced Disorders (48) · Substance-Related Disorders (45) · Brain Diseases (36) · Central Nervous System Diseases (36) · Urogenital Diseases (36) · Behavior (34) · Neurobehavioral Manifestations (34) · Male Urogenital Diseases (31) · Pathologic Processes (31)
Cognitive Behavioral Therapy (7) · Dexmedetomidine (7) · Ketamine (6) · Memantine (6) · Tadalafil (6) · Naltrexone (5) · Sugars (5) · Donepezil (4) · Melatonin (4) · Minocycline (4) · Transcranial Direct Current Stimulation (4) · Dextromethorphan (3) · Methylphenidate (3) · Midazolam (3) · Sildenafil Citrate (3)
Apurano Pharmaceuticals GmbH (8) · Rambam Health Care Campus (7) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (5) · National Taiwan University Hospital (5) · Hospital de Clinicas de Porto Alegre (4) · National Cheng-Kung University Hospital (4) · Azidus Brasil (3) · Bellus Health Inc. - a GSK company (3) · Ruijin Hospital (3) · Shanghai Mental Health Center (3) · Universiti Sains Malaysia (3) · Assiut University (2) · Bankole Johnson (2) · Beersheva Mental Health Center (2) · Biolab Sanus Farmaceutica (2)
United States (49) · Canada (20) · China (20) · Germany (20) · Brazil (18) · Israel (15) · United Kingdom (9) · Taiwan (8) · France (7) · Netherlands (6) · Spain (6) · Australia (5) · Italy (5) · South Korea (5) · Egypt (4)
Bomin Sun, MD, PhD (3) · Ilan Gruenwald, MD (2) · Mark Weiser, MD (2) · Martin Brecher, MD (2) · Ru-Band Lu, MD (2) · Tzu-Yun Wang (2) · Valerie Taylor, MD, PhD (2) · Vicknasingam Kasinather, PhD (2) · Yoram Vardi, Prof. (2) · Adrian Raine, D.Phil. (1) · Ahmed Abdelhalem (1) · Alain Brunet, Ph.D. (1)
PMID 23273725, PMID 37142273, PMID 10465680, PMID 10622350, PMID 10686270, PMID 10917410, PMID 10990547, PMID 11063978, PMID 11318766, PMID 11458304, PMID 11723286, PMID 12244081, PMID 12813115, PMID 12849360, PMID 12873949, PMID 12949224, PMID 14677403, PMID 15026214, PMID 1503131, PMID 15147306, PMID 1517644, PMID 15212606, PMID 15285956, PMID 15328899, PMID 15351385, PMID 15644873, PMID 15677610, PMID 15748841, PMID 15919269, PMID 15987799, PMID 16002441, PMID 16390886, PMID 16490414, PMID 16794566, PMID 16894061, PMID 17074942, PMID 17210143, PMID 17341537, PMID 17541113, PMID 17591596, PMID 18073775, PMID 18188442, PMID 18303488, PMID 18704022, PMID 18801471, PMID 19058788, PMID 19332318, PMID 19403329, PMID 19671217, PMID 19853048
2005 (1), 2009 (1), 2015 (1), 2023 (1), K01DA019446 (1), K08MH001516 (1), P20GM103425 (1), P20RR020146 (1), R01AA009892 (1), R01AA012178 (1), R01AG016381 (1), R01DA017296 (1), R01DA019804 (1), R01HD021453 (1), R01MH081854 (1)